Howard Hughes Medical Institute’s Ralph Lauren RL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8
Closed -$2.83K 391
2025
Q4
$2.83K Hold
8
﹤0.01% 436
2025
Q3
$2.51K Hold
8
﹤0.01% 439
2025
Q2
$2.19K Buy
+8
New +$1.98K ﹤0.01% 456
2022
Q4
Sell
-157,000
Closed -$13.3M 36
2022
Q3
$13.3M Buy
+157,000
New +$14.8M 3.79% 6
2015
Q1
Sell
-809
Closed -$150K 189
2014
Q4
$150K Buy
809
+13
+2% +$2.24K 0.04% 131
2014
Q3
$131K Buy
+796
New +$131K 0.03% 136
2013
Q4
Sell
-948
Closed -$156K 204
2013
Q3
$156K Sell
948
-146
-13% -$25.3K 0.02% 98
2013
Q2
$190K Buy
+1,094
New +$193K 0.06% 94

Other funds holding RL

Howard Hughes Medical Institute's RL Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Ralph Lauren (RL) in Q1 2026, closing a stake of 8 shares — an estimated $2.83K sold.

Howard Hughes Medical Institute first reported a position in RL in Q2 2013 and held it in 8 quarters. The position peaked at $13.3M in Q3 2022. 786 funds tracked by Wall St. Rank hold RL as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Ralph Lauren position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 8 Ralph Lauren shares in Q1 2026, an estimated $2.83K.
  • Howard Hughes Medical Institute first reported a position in Ralph Lauren in Q2 2013 and held it in 8 quarters.
  • Howard Hughes Medical Institute's Ralph Lauren position peaked at $13.3M in Q3 2022.
  • 786 funds tracked by Wall St. Rank held Ralph Lauren as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.